EdgarLookup

BridgeBio Pharma, Inc. — All Filings

755 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 4/A 424B3 424B4 424B5 424B7 425 5 5/A 8-A12B 8-K ARS CERT CORRESP CT ORDER DEF 14A DEFA14A DEFM14A DRS DRS/A DRSLTR EFFECT PRE 14A S-1 S-1/A S-1MEF S-3ASR S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K 8-K 0001193125-21-196269 Jun 22, 2021 Jun 17, 2021
4 FORM 4 SUBMISSION 0000899243-21-025398 Jun 22, 2021 Jun 17, 2021
4 FORM 4 SUBMISSION 0000899243-21-025402 Jun 22, 2021 Jun 17, 2021
4 FORM 4 SUBMISSION 0000899243-21-025410 Jun 22, 2021 Jun 17, 2021
4 FORM 4 SUBMISSION 0000899243-21-025414 Jun 22, 2021 Jun 17, 2021
8-K 8-K 0001193125-21-177835 Jun 1, 2021
4 FORM 4 SUBMISSION 0000899243-21-019798 May 18, 2021 May 16, 2021
4 FORM 4 SUBMISSION 0000899243-21-019799 May 18, 2021 May 16, 2021
8-K 8-K 0001193125-21-162215 May 14, 2021 May 6, 2021
8-K 8-K 0001193125-21-157729 May 11, 2021
10-Q 10-Q 0001564590-21-025064 May 6, 2021 Mar 31, 2021
DEF 14A DEF 14A 0001193125-21-145491 Apr 30, 2021 Jun 17, 2021
8-K 8-K 0001193125-21-117878 Apr 15, 2021 Apr 13, 2021
8-K 8-K 0001193125-21-101373 Mar 31, 2021 Mar 29, 2021
4 FORM 4 SUBMISSION 0000899243-21-009369 Mar 3, 2021 Mar 1, 2021
8-K 8-K 0001193125-21-058156 Feb 26, 2021 Feb 25, 2021
10-K 10-K 0001564590-21-008969 Feb 25, 2021 Dec 31, 2020
4 FORM 4 SUBMISSION 0000899243-21-007172 Feb 18, 2021 Feb 17, 2021
4 FORM 4 SUBMISSION 0000899243-21-007211 Feb 18, 2021 Feb 16, 2021
4 FORM 4 SUBMISSION 0000899243-21-007227 Feb 18, 2021 Feb 16, 2021
8-K 8-K 0001193125-21-046513 Feb 17, 2021 Feb 11, 2021
SC 13D/A SC 13D/A 0001140361-21-005265 Feb 17, 2021
SC 13G/A SC 13G/A 0001193125-21-045151 Feb 16, 2021
424B7 424B7 0001193125-21-045260 Feb 16, 2021
SC 13G/A SC 13G/A 0001193125-21-044721 Feb 16, 2021
4 FORM 4 SUBMISSION 0000899243-21-006433 Feb 12, 2021 Feb 10, 2021
5 FORM 5 SUBMISSION 0000899243-21-006293 Feb 12, 2021 Dec 31, 2020
4 FORM 4 SUBMISSION 0000899243-21-006432 Feb 12, 2021 Feb 10, 2021
424B7 424B7 0001193125-21-038747 Feb 11, 2021
SC 13G SCHEDULE 13G 0001104659-21-017620 Feb 10, 2021
SC 13G 0000834237-21-007395 Feb 5, 2021
8-K 8-K 0001193125-21-021591 Jan 29, 2021 Jan 25, 2021
4 FORM 4 SUBMISSION 0000899243-21-003676 Jan 28, 2021 Jan 26, 2021
8-K 8-K 0001193125-21-017108 Jan 26, 2021
4 FORM 4 SUBMISSION 0000899243-21-003286 Jan 26, 2021
SC 13D/A SC 13D/A 0001193125-21-017128 Jan 26, 2021
SC 13D/A SC 13D/A #1 0001193125-21-017733 Jan 26, 2021
8-K 8-K 0001193125-21-017810 Jan 26, 2021 Jan 25, 2021
S-8 S-8 0001193125-21-016252 Jan 25, 2021
S-8 S-8 0001193125-21-016258 Jan 25, 2021
8-K 8-K 0001193125-21-012440 Jan 20, 2021 Jan 19, 2021
425 425 0001193125-21-008184 Jan 13, 2021
8-K 8-K 0001193125-21-006802 Jan 12, 2021
425 8-K 0001193125-21-006803 Jan 12, 2021
8-K 8-K 0001193125-21-001019 Jan 4, 2021 Dec 31, 2020
425 425 0001193125-21-001014 Jan 4, 2021
4 FORM 4 SUBMISSION 0000899243-20-035444 Dec 29, 2020 Dec 28, 2020
4 FORM 4 SUBMISSION 0000899243-20-035011 Dec 23, 2020 Dec 21, 2020
4 FORM 4 SUBMISSION 0000899243-20-034688 Dec 21, 2020 Dec 18, 2020
4 FORM 4 SUBMISSION 0000899243-20-034280 Dec 17, 2020 Dec 15, 2020